PDCD1 and atherosclerosis: Preclinical studies have shown that the targets of ICIs [PD-1 (programmed cell death protein 1), PD-L1 (programmed death ligand 1), CTLA-4 (cytotoxic T-lymphocyte–associated protein4)] are proteins with a negative regulatory role in atherosclerosis [135].